Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Equity Income: 2019

Historic Equity Income for Neurocrine Biosciences (NBIX) over the last 1 years, with Dec 2019 value amounting to -$13.0 million.

  • Neurocrine Biosciences' Equity Income fell 17.14% to -$8.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$3.2 million, marking a year-over-year increase of 83.49%. This contributed to the annual value of -$13.0 million for FY2019, which is N/A change from last year.
  • According to the latest figures from FY2019, Neurocrine Biosciences' Equity Income is -$13.0 million.
  • Neurocrine Biosciences' 5-year Equity Income high stood at -$13.0 million for FY2019, and its period low was -$13.0 million during FY2019.
  • For the 1-year period, Neurocrine Biosciences' Equity Income averaged around -$13.0 million, with its median value being -$13.0 million (2019).